Clinical trial
A Dose Escalation Study of E7107 Administered IV (Bolus) on Days 1, 8, and 15…
NCT00459823 · Eisai Limited, Industry · Suspended
Key facts
| NCT number | NCT00459823 |
|---|---|
| Title | A Dose Escalation Study of E7107 Administered IV (Bolus) on Days 1, 8, and 15 Every 28 Days to Patients With Solid Tumours |
| Official title | A Phase I Open-Label, Single-Arm, Dose Escalation Study of E7107 Administered IV (Bolus) on Days 1, 8, and 15 Every 28 Days to Patients With Solid Tumours |
| Lead sponsor | Eisai Limited, Industry |
| Status | Suspended |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug |
| Interventions | E7107 |
| Enrollment | 40 |
| Start date | May 1, 2007 |
| Primary completion | Jun 1, 2009 |
| First posted | Apr 13, 2007 |
| Last update posted | Mar 24, 2009 |
| Countries | Netherlands, Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: